We are live on ! Find out more
BA

Bennicas & Associates Portfolio holdings

AUM $173M
1-Year Est. Return 1.55%
This Fund
S&P 500
This Quarter Est. Return
-2.19%
1 Year Est. Return
+1.55%
3 Year Est. Return
+40.28%
5 Year Est. Return
+86.07%
10 Year Est. Return
–
AUM
$111M
AUM Growth
+$707K
Cap. Flow
+$4.05M
Cap. Flow %
3.67%
Top 10 Hldgs %
36.5%
Holding
89
New
5
Increased
11
Reduced
43
Closed
1

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$1.89M
2
GILD icon
Gilead Sciences
GILD
+$1.69M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$742K
4
OHI icon
Omega Healthcare
OHI
+$241K
5
SNY icon
Sanofi
SNY
+$167K

Top Sells

Rank Stock Value
1
HR
Healthcare Realty Trust Incorporated
HR
+$211K
2
PG icon
Procter & Gamble
PG
+$157K
3
DOC icon
Healthpeak Properties
DOC
+$78.7K
4
PHYS icon
Sprott Physical Gold
PHYS
+$60.1K
5
MSFT icon
Microsoft
MSFT
+$53.3K

Sector Composition

Rank Sector Weight
1 Consumer Staples 23.06%
2 Healthcare 12.94%
3 Technology 10.65%
4 Materials 8.46%
5 Industrials 7.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WY icon
26
Weyerhaeuser
WY
$17.3B
$1.43M 1.29%
47,478
-200
-0.4% -$6.16K
LLY icon
27
Eli Lilly
LLY
$1.02T
$1.41M 1.27%
19,100
-100
-0.5% -$7.45K
UL icon
28
Unilever
UL
$133B
$1.33M 1.21%
29,124
-89
-0.3% -$4.15K
KMB icon
29
Kimberly-Clark
KMB
$36B
$1.32M 1.2%
11,600
– –
RTX icon
30
RTX Corp
RTX
$262B
$1.32M 1.19%
19,133
-318
-2% -$21.1K
VZ icon
31
Verizon
VZ
$182B
$1.3M 1.18%
24,387
-100
-0.4% -$5K
UPS icon
32
United Parcel Service
UPS
$96.2B
$1.29M 1.17%
11,300
– –
CPRT icon
33
Copart
CPRT
$25.5B
$1.28M 1.16%
184,600
-1,600
-0.9% -$10.9K
LMT icon
34
Lockheed Martin
LMT
$117B
$1.23M 1.11%
4,925
– –
ABBV icon
35
AbbVie
ABBV
$448B
$1.18M 1.07%
18,910
– –
PAAS icon
36
Pan American Silver
PAAS
$17.8B
$1.18M 1.07%
78,450
+1,900
+2% +$30.6K
SNY icon
37
Sanofi
SNY
$105B
$1.13M 1.02%
27,884
+4,250
+18% +$167K
TTE icon
38
TotalEnergies
TTE
$180B
$1.12M 1.02%
22,050
– –
BG icon
39
Bunge Global
BG
$23.4B
$1.1M 1%
15,250
– –
JNJ icon
40
Johnson & Johnson
JNJ
$599B
$1.09M 0.98%
9,425
– –
ASA
41
ASA Gold and Precious Metals
ASA
$914M
$1.03M 0.93%
93,580
– –
VTR icon
42
Ventas
VTR
$46.8B
$982K 0.89%
15,700
– –
DNP icon
43
DNP Select Income Fund
DNP
$4.16B
$928K 0.84%
90,729
– –
ORCL icon
44
Oracle
ORCL
$350B
$907K 0.82%
23,600
-1,200
-5% -$46.9K
QCOM icon
45
Qualcomm
QCOM
$180B
$890K 0.8%
13,650
– –
COP icon
46
ConocoPhillips
COP
$141B
$863K 0.78%
17,220
– –
PFE icon
47
Pfizer
PFE
$141B
$856K 0.77%
27,780
-316
-1% -$9.65K
BUD icon
48
AB InBev
BUD
$156B
$812K 0.73%
7,700
– –
LEG icon
49
Leggett & Platt
LEG
$1.46B
$802K 0.73%
16,400
– –
DOC icon
50
Healthpeak Properties
DOC
$15.4B
$782K 0.71%
26,324
-2,580
-9% -$78.7K
1
2
3 4

Similar funds

CCM
Cribstone Capital Management Augusta, Maine $172M AUM 13.58% 1-Year Est. Return
AWM
Aevitas Wealth Management Wellesley Hills, Massachusetts $169M AUM 9.55% 1-Year Est. Return
S
Schroders London, United Kingdom $185M AUM 16.04% 1-Year Est. Return
BFS
Bickling Financial Services Lexington, Massachusetts $160M AUM 18.81% 1-Year Est. Return
SCM
Snowhook Capital Management New York $187M AUM 31.24% 1-Year Est. Return
RCC
Red Cedar Capital Omaha, Nebraska $158M AUM 6.57% 1-Year Est. Return
WWA
WC Walker & Associates Fullerton, California $189M AUM 16.91% 1-Year Est. Return
NEGWA
New England Guild Wealth Advisors Avon, Connecticut $190M AUM 17.1% 1-Year Est. Return

Bennicas & Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Bennicas & Associates held 89 positions worth $111M, up 0.64% from $110M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Bennicas & Associates deployed $4.05M of net new capital in Q4 2016, opening 5 new positions and adding to 11 existing holdings. Its largest new stake was Kellanova: 27,158 shares worth $1.88M.

By sector, the portfolio is most concentrated in Consumer Staples at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Procter & Gamble, an estimated $157K trimmed.

  • Bennicas & Associates's largest Q4 2016 buy was Kellanova: 27,158 shares worth $1.88M.
  • Bennicas & Associates added most to Sanofi in Q4 2016, an estimated $167K increase.
  • Bennicas & Associates's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $157K.
  • Bennicas & Associates fully exited Healthcare Realty Trust Incorporated in Q4 2016, selling an estimated $211K.
  • Bennicas & Associates's ten largest holdings make up 37% of its $111M portfolio in Q4 2016.
  • Bennicas & Associates opened 5 new positions and closed 1 in Q4 2016.
  • Bennicas & Associates's portfolio value rose 0.64% quarter-over-quarter to $111M.

Based on Bennicas & Associates's 13F filing for Q4 2016, filed 19 Jan 2017.